Poland· PL-100161869
Ammonaps
A sodium phenylbutyrate product containing natrii phenylbutyras, registered in Poland by Immedica Pharma AB. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sodium phenylbutyrate is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AX03 (sodium phenylbutyrate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Sodium phenylbutyrate · ATC A16AX03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sodium phenylbutyrate costs, country by country.
Normalised to the WHO defined daily dose (20 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sodium phenylbutyrate · price per daily dose (20 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.46
The record
At a glance
URPL (Poland)- Active substance
- Natrii phenylbutyras
- Manufacturer
- Immedica Pharma AB
- Country
- Poland (PL)
- ATC code
- A16AX03
- ATC class
- Sodium phenylbutyrate
- Defined daily dose
- 20 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990609352
- gtin05909990609369
- gtin07350110580408
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium phenylbutyrate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAMMONAPS 500 MG COMPRIMIDOSImmedica Pharma Ab
- IcelandAmmonapsImmedica Pharma AB
- NetherlandsAmmonaps 500 mg tablettenImmedica Pharma AB
- FrancePHEBURANE 350 mg/mL, solution buvableEUROCEPT INTERNATIONAL (PAYS-BAS)
- Japanフェニル酪酸ナトリウムオーファンパシフィック
- ItalyPHEBURANE*orale grat sosp 174 g 483 mg/gEUROCEPT INTERNATIONAL B.V.
- CzechiaPHEBURANEEurocept International BV, Ankeveen
- SwitzerlandPheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum EinnehmenMedius AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c293251e-e2c6-4b21-ba86-8bbc0c68ca4b GET /v1/drugs/c293251e-e2c6-4b21-ba86-8bbc0c68ca4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "500 mg",
"packaging": "05909990609352 ¦ Rpz ¦ Skasowane ¦ EU/1/99/120/001 ¦ 33097\n250 tabl.\n05909990609369 ¦ Rpz ¦ EU/1/99/120/002 ¦ 33098\n500 tabl.\n07350110580408 ¦ Rpz ¦ EU/1/99/120/001 ¦ 167365\n250 tabl.",
"substance": "Natrii phenylbutyras 500 mg",
"common_name": "Natrii phenylbutyras",
"pl_product_id": "100161869",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sodium phenylbutyrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.